original ) (raw )The role of serum testosterone to prostate-specific antigen ratio as a predictor of prostate cancer risk
Turhan Caskurlu
The Kaohsiung Journal of Medical Sciences, 2012
View PDFchevron_right
Determined Free Serum Testosterone is Better than Total Testosterone as a Predictor of Prostate Cancer Risk
Ana Celma
2015
View PDFchevron_right
Low testosterone bioavailability is related to prostate cancer diagnose in patients submitted to prostate biopsy
Agustín Franco
World Journal of Urology, 2012
View PDFchevron_right
Correlation Between Serum Testosterone, Biochemical and Clinical Markers in Prostate Cancer Patients
Bistra Galunska
Journal of IMAB - Annual Proceeding (Scientific Papers), 2016
View PDFchevron_right
Serum testosterone as predictor of pathological stage in prostate cancer
IP Innovative Publication Pvt. Ltd.
Innovative publication, 2016
View PDFchevron_right
Greater Percent-free Testosterone Is Associated With High-grade Prostate Cancer in Men Undergoing Prostate Biopsy
Andrea Tubaro
Urology, 2012
View PDFchevron_right
Serum Testosterone: A Potentially Adjunct Screening Test for the Assessment of the Risk of Prostate Cancer Among Men with Modestly Elevated PSA Values (≥ 3.0 and< 10.0 ng/ml)
Michael Koutsilieris
2006
View PDFchevron_right
Serum Testosterone Level, Testosterone Replacement Treatment, and Prostate Cancer
Derya Balbay
Advances in Urology, 2013
View PDFchevron_right
Low levels of serum testosterone in middle-aged men impact pathological features of prostate cancer
Ziho Lee
Prostate international, 2017
View PDFchevron_right
Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less
Ernani Luis Rhoden
Urology, 2006
View PDFchevron_right
Low endogenous testosterone level is associated with high-risk prostate-specific antigen level in men with prostate cancer disease
collins amadi
International Surgery Journal, 2018
View PDFchevron_right
Low serum testosterone is a predictor of high-grade disease in patients with prostate cancer
Guilherme Padovani
Revista da Associacao Medica Brasileira (1992), 2017
View PDFchevron_right
Predictive criteria for prostate cancer detection in men with serum PSA concentration of 2.0 to 4.0 ng/mL
sergey kravchick
Urology, 2005
View PDFchevron_right
Investigative clinical study on prostate cancer: on the role of the pretreatment total PSA to free testosterone ratio in selecting different biology groups of prostate cancer patients
Carmelo Monaco
2010
View PDFchevron_right
Testosterone as a predictor of pathological stage in clinically localized prostate cancer
Hans Lilja
The Journal of urology, 2005
View PDFchevron_right
Pretreatment Total Testosterone Level Predicts Pathological Stage in Patients With Localized Prostate Cancer Treated With Radical Prostatectomy
John Foley
The Journal of Urology, 2003
View PDFchevron_right
Testosterone Measurement in Patients with Prostate Cancer
Piotr Chlosta
European Urology, 2010
View PDFchevron_right
Serum testosterone is associated with aggressive prostate cancer in older men: results from the Baltimore Longitudinal Study of Aging
Dan Longo
BJU International, 2010
View PDFchevron_right
Association of Long-Term Dynamics in Circulating Testosterone with Serum PSA in Prostate Cancer-Free Men with Initial-PSA 4 ng/mL
Peihua Qiu
Hormones and Cancer, 2019
View PDFchevron_right
Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies
Neal Freedman
European urology, 2018
View PDFchevron_right
Testosterone Replacement Therapy in Hypogonadal Men at High Risk for Prostate Cancer: Results of 1 Year of Treatment in Men With Prostatic Intraepithelial Neoplasia
Ernani Rhoden
The Journal of Urology, 2003
View PDFchevron_right
The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy
Alessandro Terrin
Archivio italiano di urologia, andrologia : organo ufficiale [di] Società italiana di ecografia urologica e nefrologica / Associazione ricerche in urologia, 2016
View PDFchevron_right
Comparison of serum testosterone levels in prostate cancer patients
Karen Hersey
Canadian Urological Association journal, 2013
View PDFchevron_right
Aggressiveness of Localized Prostate Cancer: the Key Value of Testosterone Deficiency Evaluated by Both Total and Bioavailable Testosterone: AndroCan Study Results
Henry Botto
Hormones and Cancer, 2018
View PDFchevron_right
Testosterone treatment and the risk of aggressive prostate cancer in men with low testosterone levels
Alvin Matsumoto
PloS one, 2018
View PDFchevron_right
Endogenous testosterone to prostate-specific antigen relationship in men without prostatic diseases: a 10-year retrospective study
collins amadi
International Surgery Journal, 2018
View PDFchevron_right
Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatment
Laura Izquierdo
BJU International, 2012
View PDFchevron_right
Study of testosterone as a predictor of tumor aggressiveness in patients with prostate cancer
Sandro Cardoso , Marcelo Iwamoto
International braz j urol : official journal of the Brazilian Society of Urology
View PDFchevron_right